A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

7.3K views

DOI:

10.3791/55931

July 31st, 2017

* These authors contributed equally

In This Article

Summary

Acidic postconditioning protects against cerebral ischemia. Here we present two models to execute APC. They are achieved respectively by transferring corticostriatal slices to acidic buffer after oxygen-glucose deprivation in vitro and by inhaling 20% CO2 after middle cerebral artery occlusion in vivo.

Abstract

Stroke is one of the leading causes of mortality and disability worldwide, with limited therapeutic approaches. As an endogenous strategy for neuroprotection, postconditioning treatments have proven to be promising therapies against cerebral ischemia. However, complicated procedures and potential safety issues limit their clinical application. To overcome these disadvantages, we have developed acidic postconditioning (APC) as a therapy for experimental focal cerebral ischemia. APC refers to the mild acidosis treatment by inhaling CO2 during reperfusion following ischemia. Here we present two models to execute APC in vitro and in vivo, respectively. The oxygen-glucose deprivation (OGD) treatment of mice and the corticostriatal occlusion and middle cerebral artery occlusion (MCAO) of mice were employed to mimic cerebral ischemia. APC can be simply achieved by transferring brain slices to acidic buffer bubbled with 20% CO2, or by mice inhaling 20% CO2. APC showed significant protective effects against cerebral ischemia, as reflected by tissue viability and brain infarct volume.

Introduction

Stroke is one of the leading causes of mortality and disability worldwide. Great efforts have been made to find effective treatments for stroke in the last decades, however, the achievement is quite unsatisfactory. Postconditioning is a process manipulated by subtoxic stresses following an ischemic episode. Postconditioning, including ischemic, hypoxic, low-glucose and remote ischemic postconditioning, trigger endogenous adaptive mechanisms, and have been proven to be promising therapies against cerebral ischemia1,2,3,4. However, ischemic po....

Access restricted. Please log in or start a trial to view this content.

Protocol

All experiments were approved by and conducted in accordance with the ethical guidelines of the Zhejiang University Animal Experimentation Committee and were in complete compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Efforts were made to minimize any pain or discomfort, and the minimum number of animals was used.

1. OGD of Corticostriatal Slices

  1. Solution preparation:
    1. Prepare 1,000 mL r-ACSF (124 mmol/L, NaCl, 5 mmol/L KCl, 1.25 mmol/L KH2PO4, 2 mmol/L MgSO4, 26 mmol/L NaHCO3, 2 mmol/L CaCl2, 10....

Access restricted. Please log in or start a trial to view this content.

Results

In the corticostriatal slice model described above, corticostriatal slice viability was quantified by TTC assay at 1 h after reperfusion. TTC conversion was calculated by normalizing the absorption at 490 nm to the control slice. According to TTC conversion, APC protected against OGD-induced reperfusion injury in an onset time and duration-dependent manner. In detail, both 1 and 3 min of acidosis treatment significantly improved viability at 5 min after 15 min OGD, whereas 5 min did not (.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Here we present two experimental models to study the neuroprotection of APC against cerebral ischemia. In brain slices, APC is achieved by incubating mice corticostriatal slices in acidic buffer bubbled with 20% CO2 after reperfusion onset, while in the MCAO model, APC is achieved by inhaling 20% CO2 to mice after reperfusion. Both models reflect the neuroprotection of APC against cerebral ischemia. The protection was comparable with that achieved by ischemic postconditioning but with a wider time w.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was funded by the National Natural Science Foundation of China (81573406, 81373393, 81273506, 81221003, 81473186 and 81402907), Zhejiang Provincial Natural Science Foundation (LR15H310001) and the Program for Zhejiang Leading Team of S&T Innovation Team (2011R50014).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Sodium chlorideSigmaS5886
Potassium chlorideSigmaP5405
Potassium phosphate monobasicSigmaP9791
Magnesium sulfateSigmaM2643
Sodium bicarbonateSigmaS5761
Calcium chloride dihydrateSigmaC5080
D-(+)-GlucoseSigmaG7021
VibratomeLeicaVT1000 S
2,3,5-triphenyltetrazolium hydrochlorideSigmaT8877
Absolute EthanolAladdin Industrial CorporationE111993
Dimethyl sulfoxideSigmaD8418
Laser Doppler FlowmetryMoor Instruments LtdModel Moor VMS-LDF2
Diethyl ether anhydrousSinopharm Chemical Reagent Corporation80059618
Trichloroacetaldehycle hydrateSinopharm Chemical Reagent Corporation30037517
10% FormalinAladdin Industrial CorporationF111936
24-well platesJet BiofilTCP-010-024

References

  1. Zhao, H., Sapolsky, R. M., Steinberg, G. K. Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab. 26 (9), 1114-1121 (2006).
  2. Leconte, C., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Oxygen Glucose DeprivationMiddle Cerebral Artery OcclusionCorticostriatal OcclusionBrain Slice ModelTTC AssayCO2 InhalationNeuroprotection StudyIschemic Brain Injury